InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Verneuil Vanina de
3 Nov 2026
EVP, General Counsel, Corp Sec
Sold on a plan
2,407
$11.10
$26.72K
Verneuil Vanina de
2 Nov 2026
EVP, General Counsel, Corp Sec
Sold on a plan
1,343
$11.33
$15.22K
Brent Sabatini
1 Jun 2026
SVP, Chief Accounting Officer
Sold on a plan
379
$9.45
$3.58K
Janet Napolitano
1 Jun 2026
Director
Sold on a plan
3,200
$9.45
$30.24K
Vicki L Sato
1 May 2026
Director
Sold on a plan
22,000
$10.05
$221.03K
Backer Marianne De
6 Apr 2026
President and CEO
Sold on a plan
72,559
$9.16
$664.35K
Vicki L Sato
1 Apr 2026
Director
Sold on a plan
22,000
$9.07
$199.62K
Brent Sabatini
23 Mar 2026
SVP, Chief Accounting Officer
Sold on a plan
7,711
$9.12
$70.32K
Vicki L Sato
2 Mar 2026
Director
Sold on a plan
200
$9.98
$2.00K
Vicki L Sato
2 Mar 2026
Director
Sold on a plan
21,800
$9.50
$207.19K
Verneuil Vanina de
25 Feb 2026
EVP, General Counsel, Corp Sec
Sold on a plan
13,700
$9.82
$134.53K
Mark Eisner
25 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
1,889
$9.82
$18.55K
Backer Marianne De
24 Feb 2026
Chief Executive Officer
Sold on a plan
14,762
$9.53
$140.72K
Verneuil Vanina de
24 Feb 2026
EVP, General Counsel, Corp Sec
Sold on a plan
3,117
$9.53
$29.71K
Mark Eisner
24 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
1,616
$9.53
$15.40K
Jason O'Byrne
24 Feb 2026
EVP & Chief Financial Officer
Sold on a plan
1,634
$9.53
$15.58K
Brent Sabatini
24 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
1,430
$9.53
$13.63K
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
200
$10.26
$2.05K
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
42,177
$9.75
$411.31K
Backer Marianne De
23 Feb 2026
Chief Executive Officer
Sold on a plan
19,039
$7.45
$141.89K
Verneuil Vanina de
23 Feb 2026
EVP, General Counsel, Corp Sec
Sold on a plan
4,445
$7.45
$33.13K
Mark Eisner
23 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
2,089
$7.45
$15.57K
Jason O'Byrne
23 Feb 2026
EVP & Chief Financial Officer
Sold on a plan
2,089
$7.45
$15.57K
Brent Sabatini
23 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
1,829
$7.45
$13.63K
Brent Sabatini
13 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
1,530
$7.79
$11.92K
Vicki L Sato
2 Feb 2026
Director
Sold on a plan
22,000
$7.71
$169.67K
Vicki L Sato
2 Jan 2026
Director
Sold on a plan
22,000
$5.93
$130.38K
Vicki L Sato
1 Dec 2025
Director
Sold on a plan
22,000
$6.00
$132.07K
SVF Endurance (Cayman) Ltd
1 Dec 2025
10% owner
Sold on a plan indirect
191,854
$5.98
$1.15M
SVF Endurance (Cayman) Ltd
28 Nov 2025
10% owner
Sold on a plan indirect
61,493
$6.44
$396.01K
SVF Endurance (Cayman) Ltd
26 Nov 2025
10% owner
Sold on a plan indirect
127,938
$6.39
$817.65K
SVF Endurance (Cayman) Ltd
25 Nov 2025
10% owner
Sold on a plan indirect
235,971
$6.38
$1.51M
SVF Endurance (Cayman) Ltd
24 Nov 2025
10% owner
Sold on a plan indirect
227,803
$6.15
$1.40M
Jason O'Byrne
17 Nov 2025
EVP & Chief Financial Officer
Sold on a plan
6,799
$5.56
$37.78K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 32
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,082,172
History held since 10 Oct 2019